MedPath

Betamethasone administration in preterm labor.

Phase 3
Conditions
Preterm labor.
Preterm labour and delivery
Registration Number
IRCT201402072624N11
Lead Sponsor
Vice chancellor for research ,Iran University of Medical Sciences.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

singleton pregnancy and gestational age of 26-34 weeks.
Exclusion criteria: known allergy for betamethazone; history of any known maternal systemic disorders like hypertension, diabetes, liver and cardiac disease, renal failure and neoplasia.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Respiratory distress syndrome. Timepoint: After delivery. Method of measurement: sign and symptoms by pediatrician.
Secondary Outcome Measures
NameTimeMethod
Intra ventricular hemorrhage. Timepoint: After birth up to discharge. Method of measurement: Diagnosis by pediatrician.;Retinopathy. Timepoint: After birth up to discharge. Method of measurement: Diagnosis by ophtalmologist.;Necrotizing enter colitis. Timepoint: After birth up to discharge. Method of measurement: Diagnosis by pediatrician.;Neonatal death. Timepoint: After birth up to discharge. Method of measurement: neonatal sheet.;NICU admission. Timepoint: After birth up to discharge. Method of measurement: neonatal sheet.
© Copyright 2025. All Rights Reserved by MedPath